Research Article

Primary Percutaneous Coronary Intervention with High-Bolus Dose Tirofiban: The FASTER (Favorite Approach to Safe and Effective Treatment for Early Reperfusion) Multicenter Registry

Table 1

Inclusion and exclusion criteria

Inclusion criteriaExclusion criteria

Age 18–85 yearsContraindications to use of tirofiban
STEMI within 12 hours from symptoms onset with high thrombus burdenPatients with left bundle branch block
ST-segment elevation >1 mm in 2 adjacent ECG leadsTherapy resistant cardiogenic shock
Patients eligible for primary PCI within 120 minutes after first medical contactPersistent severe hypertension (systolic BP >180 mmHg or diastolic BP >110 mmHg)
Contraindication to anticoagulation
Pregnant or breastfeeding women